We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$651M
AUM Growth
+$83.6M
Cap. Flow
+$27.1M
Cap. Flow %
4.16%
Top 10 Hldgs %
35.18%
Holding
155
New
7
Increased
80
Reduced
42
Closed
13

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$11.7M
2
JBTM
JBT Marel
JBTM
+$6.95M
3
CNNE icon
Cannae Holdings
CNNE
+$5.5M
4
PHIN icon
Phinia Inc
PHIN
+$4.84M
5
TTGT icon
TechTarget
TTGT
+$1.76M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.52%
2 Technology 22.04%
3 Financials 13.51%
4 Industrials 8.82%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVV icon
51
Valvoline
VVV
$4.97B
$2.85M 0.44%
75,299
-3,985
-5% -$139K
ARES icon
52
Ares Management
ARES
$28.5B
$2.79M 0.43%
16,105
+4,354
+37% +$689K
STLD icon
53
Steel Dynamics
STLD
$35.6B
$2.77M 0.43%
21,668
+6,972
+47% +$890K
MLR icon
54
Miller Industries
MLR
$586M
$2.7M 0.41%
60,752
-3,042
-5% -$132K
VIG icon
55
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.63M 0.4%
12,868
ORCL icon
56
Oracle
ORCL
$331B
$2.63M 0.4%
12,043
+3,966
+49% +$640K
LRCX icon
57
Lam Research
LRCX
$382B
$2.63M 0.4%
26,991
+8,659
+47% +$687K
WBS icon
58
Webster Financial
WBS
$12.3B
$2.6M 0.4%
47,532
-4,570
-9% -$228K
OSW icon
59
OneSpaWorld
OSW
$2.67B
$2.56M 0.39%
125,618
-7,604
-6% -$139K
BELFA icon
60
Bel Fuse Inc Class A
BELFA
$3.32B
$2.54M 0.39%
28,250
+9,008
+47% +$624K
NCNO icon
61
nCino
NCNO
$1.81B
$2.34M 0.36%
83,668
-10,405
-11% -$260K
HQY icon
62
HealthEquity
HQY
$7.91B
$2.34M 0.36%
22,292
-6,776
-23% -$642K
ACN icon
63
Accenture
ACN
$89.9B
$2.29M 0.35%
7,669
+2,427
+46% +$739K
DSGR icon
64
Distribution Solutions Group
DSGR
$1.6B
$2.26M 0.35%
82,131
-4,885
-6% -$131K
NTAP icon
65
NetApp
NTAP
$32.9B
$2.24M 0.34%
21,021
+6,875
+49% +$652K
AZO icon
66
AutoZone
AZO
$48.3B
$2.19M 0.34%
590
-8
-1% -$29.5K
VCSH icon
67
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.06M 0.32%
25,912
+570
+2% +$44.9K
MCRI icon
68
Monarch Casino & Resort
MCRI
$2.14B
$2.04M 0.31%
23,567
-1,595
-6% -$129K
AX icon
69
Axos Financial
AX
$5.45B
$2.01M 0.31%
26,445
+6,075
+30% +$411K
JPM icon
70
JPMorgan Chase
JPM
$939B
$1.99M 0.31%
6,872
-134
-2% -$34.2K
JEF icon
71
Jefferies Financial Group
JEF
$12.9B
$1.95M 0.3%
+35,660
New +$1.77M
EME icon
72
Emcor
EME
$33.1B
$1.94M 0.3%
3,630
+1,192
+49% +$526K
EHC icon
73
Encompass Health
EHC
$11.2B
$1.91M 0.29%
15,547
+1,058
+7% +$121K
RSP icon
74
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$1.89M 0.29%
10,394
+2
+0% +$345
ALKT icon
75
Alkami Technology
ALKT
$1.8B
$1.87M 0.29%
+62,040
New +$1.72M

Similar funds

Advisory Research's Q2 2025 Portfolio in Review

As of Q2 2025, Advisory Research held 155 positions worth $651M, up 15% from $567M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Advisory Research deployed $27.1M of net new capital in Q2 2025, opening 7 new positions and adding to 80 existing holdings. Its largest new stake was REV Group: 72,570 shares worth $3.45M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JBT Marel, an estimated $6.95M trimmed.

  • Advisory Research's largest Q2 2025 buy was REV Group: 72,570 shares worth $3.45M.
  • Advisory Research added most to Eagle Materials in Q2 2025, an estimated $8.17M increase.
  • Advisory Research's biggest Q2 2025 reduction was JBT Marel, cutting an estimated $6.95M.
  • Advisory Research fully exited iShares MSCI ACWI ETF in Q2 2025, selling an estimated $11.7M.
  • Advisory Research's ten largest holdings make up 35% of its $651M portfolio in Q2 2025.
  • Advisory Research opened 7 new positions and closed 13 in Q2 2025.
  • Advisory Research's portfolio value rose 15% quarter-over-quarter to $651M.

Based on Advisory Research's 13F filing for Q2 2025, filed 13 Aug 2025.